Bright Eyes On TV

As shown in “The Richard & Judy Show”


Pete Aldred, appeared on the TV show, notes from the show ….

“The scene was the popular Richard and Judy Television Show. We watched as the cameras, lights and working instruments were deployed to work. We watched the film roll and the three people who were attending the preliminary eye examinations at the popular Optical Express individually examined by the specialist ophthalmic. The purpose of that examination was to have their eyes checked for cataract disease.

Actually I knew I will be on live television programme as part of the campaign for the six months test for Ethos Endymion Bright Eyes. I was a bit agitated but I retained my composure. We watched as the film showed each of the patients examined one after the other. At the end of the examination the ophthalmologist confirmed that all the three patients had cataract diseases of different senility.

In the studio, I was sitting next to John Bolger; Bolger was one of the best in the United Kingdom and in fact among the best BUPA cataract surgeons in the world. We watched as the film show John performs the cataract operation on those three patients. As the film was rolling by, John took time to explain what was involved in the cataract operation, he explained every step involved in the operation until he finished with the operation.

The performing of the surgical cataracts operation was the most difficult aspect of that show. Most of the 2.1 million TV viewers who watched that live television programme could not withstand that aspect of the show. On my own part I have never witnessed surgical cataracts operation. One will not find it hard to comprehend why Helen Aslam of Essex one of the three ladies who were shown live undergoing that surgical operation could not continue with the operation to save the other eye. She was such traumatized by her experience that she will not like to suffer the same faith again. She was very much relieved when her sister told her about the Bright Eyes Drop which she saw at C4 website. She was happy she volunteered to be one of the candidates for the clinical trials for the Bright Eyes product.

We then set the ball rolling on Bright Eyes Treatment and the benefits it offers to cataract patients. Both Richard and Judy were moderating. Everybody was surprised on how John was receptive and open to the revolutionary Bright Eyes Drops product. John saw it as a new possibility and innovatory, he was such committed to it that he would prefer to wait and see it replace cataract operation. He said, he will no longer comment on that product until the clinical trials are out.

That television outing was heroic, and people have already started reacting to it. We have been receiving countless number of phone calls to our offices by people who are seeking further information about the product.

We will like to extend our personal gratitude to the programme presenters Richard and Judy for bringing us to the programme. We are grateful to Patrick Ruddy for his untiring efforts especially in preparing the groundwork and for making everything work out in a professional way. We are appreciative of the entire people at Cactus TV who have worked hard to make the day a reality for us.

The man that owes the greatest appreciation is John Bolger for his open mindedness and for his assistance in researching the Bright Eyes which made it possible for us to start the clinical trials. We say thank you John.”

Bright Eyes Drops

Is Bright Eyes the End to Cataract Surgery?

Ethos Endymion or Bright Eyes is a new revolutionary product discovered to give an effective checkmate to the problem of cataract. Since the product was aired in the popular UK television show tagged “Richard and Judy Television Show” the popularity of the drugs has increased tremendously. The increase in the popularity is not because of the way the product was described at that television show but because of what it offers as the most effective substitute to cataract operation. The brain behind the product, Ethos has made it known that the Bright Eyes could mean an end to cataract surgical operations. The product was manufactured from the neuropeptide L-Carnosine a natural occurring substance. This is both a super antioxidant as well as anti-glycating agent. The drug penetrates deep into the eye and protects the lipid tissues from the damaging effects of glycosylation a problem that is related with eye degenerative diseases.

Cataract is a global health concern. It is one of the dreadful diseases confronting many people in the world, and health experts are concerned on how to bring it under control. At last count it was reported that about 17 million people are globally going blind as a result of cataract, with 28,000 fresh cases being reported on daily basis. It was shown that not fewer than 25% of the people who fall within the age range of 65 and 50% of the elderly people whose ages are above 80 are having serious eye impairment problem as a result of cataracts. Report had shown that at the same period in the United Kingdom alone that there are more than 500,000 patients queuing up for cataract operation; the figure for the other parts of Europe is alarming. At a particular United Kingdom hospital it was reported that 250 to 300 cataracts operations are performed every week. Addressing the backlog becomes such challenging that experts were flown in from other countries to meet with the increasing demand of cataract surgical operations.

The clinical trials for the Bright Eyes were carried out in China and Russia. In one such trial did on 96 patients who suffer from varying degrees of cataract eye problem the outcome of the trial was a resounding success for the new drug as there was 100% cure for those patients who were suffering primary senile cataract. For those sufferings from mature senile cataract disease the trial returned a recovery percentage of 80 for the six months the trials were carried out. The result was also encouraging for the patients with other forms of cataract disease. Another clinical trial conducted for cataract patients also showed an improvement rate of 41.5% to 100% within the trial period of 6 months. The result of another trial 24 months later showed much improvement in the effectiveness of the Bright Eyes as total cure to cataract. One may think that because of the effectiveness of the eye drop that the cost may be beyond reach. That is not the case; a box of Bright Eyes goes for about $100 (that is £50 or €75). A box contains 2 x 5ml bottles which is equivalent to 30 days supply that is if one applies two drops a day to each of the eyes. With more and more people acquiring more knowledge on positive effects the usage of the drugs will multiply tremendously. It is very inexpensive when is compared with the cost of a cataract operation which is put at over $3,500 (or £2,000, €3,000) just for one eye, and over $6,500 (or £3,500 or €5,000) for both eyes..